 |
 |

VitiligoTo Treat or Not to Treat
Henry W. Lim, MD;
Camile L. Hexsel, MD
Arch Dermatol. 2007;143(5):643-646.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Treatment of vitiligo involves either repigmentation or depigmentation, depending on the extent of the disease. Additional adjuvant forms of management include cosmetic cover-up and psychological and social support. Support groups can be located through the National Vitiligo Foundation (http://www.nvfi.org). Topical dihydroxyacetone-containing self-tanning preparations, topical dyes, and tattooing have also been used1 but generally do not result in ideal color match with the unaffected skin.
Based on a review of published studies, a suggested treatment algorithm is shown in the Figure. In this editorial, we review published studies of the management of vitiligo, focusing primarily on the more recent studies with a high level of evidence (Table). Level of evidence was graded on a 5-point scale as follows17: (I) at least 1 properly designed randomized controlled trial; (II-1) well-designed controlled trial without randomization; (II-2) well-designed cohort or . . . [Full Text of this Article] REPIGMENTATION PHOTOTHERAPY AND PHOTOCHEMOTHERAPY
TARGETED PHOTOTHERAPY
TOPICAL, INTRALESIONAL, AND SYSTEMIC CORTICOSTEROID AGENTS
TOPICAL CALCINEURIN INHIBITORS
TOPICAL CALCIPOTRIENE
SURGICAL REPIGMENTATION
DEPIGMENTATION
SUMMARY
AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Randomized Double-blind Trial of Treatment of Vitiligo: Efficacy of PsoralenUV-A Therapy vs NarrowbandUV-B Therapy
Sami Sasi Yones, Roy A. Palmer, Trish M. Garibaldinos, and John L. M. Hawk
Arch Dermatol. 2007;143(5):578-584.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Repigmentation in Vitiligo: PUVA vs. Narrowband UVB
Journal Watch Dermatology 2007;2007:1-1.
FULL TEXT
|